Health Care & Life Sciences » Biotechnology | Cytori Therapeutics Inc.

Cytori Therapeutics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
15,506.00
14,622.00
14,338.00
12,910.00
10,225.00
5,301
Total Accounts Receivable
4,263.00
1,360.00
1,312.00
1,295.00
257.00
377
Inventories
3,694.00
4,829.00
4,298.00
3,725.00
3,183.00
2,947
Other Current Assets
1,114.00
875.00
1,295.00
817.00
1,199.00
1,023
Total Current Assets
24,577.00
21,686.00
21,243.00
18,747.00
14,864.00
9,648
Net Property, Plant & Equipment
1,054.00
1,583.00
1,631.00
1,157.00
3,052.00
2,559
Total Investments and Advances
350.00
350.00
350.00
-
-
-
Intangible Assets
13,267.00
13,337.00
12,953.00
12,369.00
11,129.00
9,879
Other Assets
2,812.00
1,763.00
1,521.00
2,336.00
2,570.00
1,905
Total Assets
42,060.00
38,719.00
37,698.00
34,609.00
31,615.00
23,991
ST Debt & Current Portion LT Debt
3,191.00
7,363.00
-
6,629.00
13,624.00
Accounts Payable
965.00
949.00
1,009.00
1,332.00
1,297.00
Other Current Liabilities
10,750.00
7,605.00
7,428.00
4,540.00
3,493.00
Total Current Liabilities
14,906.00
15,917.00
8,437.00
12,501.00
18,414.00
Long-Term Debt
23,100.00
18,041.00
16,681.00
11,008.00
-
Other Liabilities
922.00
10,463.00
374.00
114.00
201.00
Total Liabilities
38,928.00
44,421.00
25,492.00
23,623.00
18,615.00
Common Equity (Total)
3,132.00
5,702.00
12,206.00
10,986.00
13,000.00
Total Shareholders' Equity
3,132.00
5,702.00
12,206.00
10,986.00
13,000.00
Total Equity
3,132.00
5,702.00
12,206.00
10,986.00
13,000.00
Liabilities & Shareholders' Equity
42,060.00
38,719.00
37,698.00
34,609.00
31,615.00

About Cytori Therapeutics

View Profile
Address
3020 Callan Road
San Diego California 92121
United States
Employees -
Website http://www.cytori.com
Updated 07/08/2019
Cytori Therapeutics, Inc. is a late stage cell therapy company which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions. It offers the Cytori Nanomedicine, Cytori Cell Therapy, and other clinical trials. The company was founded by Ralph E.